Literature DB >> 24048879

Role of NUCB2/Nesfatin-1 in the hypothalamic control of energy homeostasis.

A Stengel1, Y Taché2.   

Abstract

Hunger and satiety are regulated in a complex fashion by a few food intake stimulatory (orexigenic) and a multitude of inhibitory (anorexigenic) factors produced in the periphery (mainly in the gastrointestinal tract) or directly in the brain. Within the brain, the hypothalamus plays a pivotal role as a production site of food intake regulatory factors. Importantly, this site integrates peripheral and central signaling factors to orchestrate food intake and in the long term body weight. Our knowledge on these regulatory pathways is not static but rather rapidly changing as new factors as well as up- and downstream signaling pathways of already known transmitters are uncovered. Hypothalamic nucleobindin2 (NUCB2), the precursor of nesfatin-1, was first described in 2006 and nesfatin-1 found to be a novel anorexigenic modulator of food intake and body weight. The initial report stimulated several groups to investigate the biological actions of nesfatin-1 and subsequent studies delineated the underlying brain mechanisms involved in its food reducing effect. Of interest was the demonstration that NUCB2 also exerts its anorexigenic action in the paraventricular nucleus of the hypothalamus and is regulated at this site by changes in metabolic status with a diurnal rhythm inversely related to that of feeding in rats. The present review describes the current state-of-knowledge on central nesfatin-1's effects on food intake and body weight and highlights important missing links regarding cellular signaling mechanisms involved in nesfatin-1's action. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24048879      PMCID: PMC5939559          DOI: 10.1055/s-0033-1351324

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  51 in total

Review 1.  Central nervous system control of food intake.

Authors:  M W Schwartz; S C Woods; D Porte; R J Seeley; D G Baskin
Journal:  Nature       Date:  2000-04-06       Impact factor: 49.962

2.  The anorexigenic and hypertensive effects of nesfatin-1 are reversed by pretreatment with an oxytocin receptor antagonist.

Authors:  Gina L C Yosten; Willis K Samson
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-03-24       Impact factor: 3.619

3.  Nesfatin-1 exerts long-term effect on food intake and body temperature.

Authors:  K Könczöl; O Pintér; S Ferenczi; J Varga; K Kovács; M Palkovits; D Zelena; Z E Tóth
Journal:  Int J Obes (Lond)       Date:  2012-01-31       Impact factor: 5.095

4.  Identification of nesfatin-1 as a satiety molecule in the hypothalamus.

Authors:  Shinsuke Oh-I; Hiroyuki Shimizu; Tetsurou Satoh; Shuichi Okada; Sachika Adachi; Kinji Inoue; Hiroshi Eguchi; Masanori Yamamoto; Toshihiro Imaki; Koushi Hashimoto; Takafumi Tsuchiya; Tsuyoshi Monden; Kazuhiko Horiguchi; Masanobu Yamada; Masatomo Mori
Journal:  Nature       Date:  2006-10-01       Impact factor: 49.962

5.  Localization of nesfatin-1 neurons in the mouse brain and functional implication.

Authors:  Miriam Goebel-Stengel; Lixin Wang; Andreas Stengel; Yvette Taché
Journal:  Brain Res       Date:  2011-04-22       Impact factor: 3.252

6.  Plasma nesfatin-1 concentrations in restricting-type anorexia nervosa.

Authors:  Kazuma Ogiso; Akihiro Asakawa; Haruka Amitani; Toshihiro Nakahara; Miharu Ushikai; Izumi Haruta; Ken-Ichiro Koyama; Marie Amitani; Toshiro Harada; Daisuke Yasuhara; Akio Inui
Journal:  Peptides       Date:  2010-10-19       Impact factor: 3.750

7.  Possible involvement of hypothalamic nucleobindin-2 in hyperphagic feeding in Tsumura Suzuki obese diabetes mice.

Authors:  Shigeo Miyata; Nao Yamada; Tomie Kawada
Journal:  Biol Pharm Bull       Date:  2012       Impact factor: 2.233

8.  PVN-hindbrain pathway involved in the hypothalamic hyperphagia-obesity syndrome.

Authors:  A L Kirchgessner; A Sclafani
Journal:  Physiol Behav       Date:  1988

9.  Nesfatin-1 exerts cardiovascular actions in brain: possible interaction with the central melanocortin system.

Authors:  Gina L C Yosten; Willis K Samson
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-05-27       Impact factor: 3.619

10.  Central nesfatin-1 reduces dark-phase food intake and gastric emptying in rats: differential role of corticotropin-releasing factor2 receptor.

Authors:  Andreas Stengel; Miriam Goebel; Lixin Wang; Jean Rivier; Peter Kobelt; Hubert Mönnikes; Nils W G Lambrecht; Yvette Taché
Journal:  Endocrinology       Date:  2009-10-01       Impact factor: 4.736

View more
  7 in total

Review 1.  NUCB2: roles in physiology and pathology.

Authors:  Qing Zhou; Ying Liu; Ranran Feng; Wenling Zhang
Journal:  J Physiol Biochem       Date:  2022-06-09       Impact factor: 5.080

2.  NUCB2/nesfatin-1 Is Associated with Elevated Levels of Anxiety in Anorexia Nervosa.

Authors:  Tobias Hofmann; Anne Ahnis; Ulf Elbelt; Matthias Rose; Burghard F Klapp; Andreas Stengel
Journal:  PLoS One       Date:  2015-07-10       Impact factor: 3.240

3.  Editorial: Trends in Neuroendocrinology.

Authors:  Hubert Vaudry
Journal:  Front Endocrinol (Lausanne)       Date:  2016-05-18       Impact factor: 5.555

4.  Nesfatin-1/Nucleobindin-2 enhances cell migration, invasion, and epithelial-mesenchymal transition via LKB1/AMPK/TORC1/ZEB1 pathways in colon cancer.

Authors:  Jung-Yu Kan; Meng-Chi Yen; Jaw-Yuan Wang; Deng-Chyang Wu; Yen-Jung Chiu; Ya-Wen Ho; Po-Lin Kuo
Journal:  Oncotarget       Date:  2016-05-24

5.  Identification of Nucleobindin-2 as a Potential Biomarker for Breast Cancer Metastasis Using iTRAQ-based Quantitative Proteomic Analysis.

Authors:  Liang Zeng; Jingmin Zhong; Guangchun He; Fangjun Li; Jing Li; Wen Zhou; Wenbin Liu; Yun Zhang; Sanqian Huang; Zhihong Liu; Xiyun Deng
Journal:  J Cancer       Date:  2017-09-02       Impact factor: 4.207

6.  Nesfatin-1/Nucleobindin-2 Is a Potent Prognostic Marker and Enhances Cell Proliferation, Migration, and Invasion in Bladder Cancer.

Authors:  Guang-Ming Liu; Zi-Qiang Xu; Hong-Shun Ma
Journal:  Dis Markers       Date:  2018-09-19       Impact factor: 3.434

7.  The first identification of nesfatin-1-expressing neurons in the human bed nucleus of the stria terminalis.

Authors:  Artur Pałasz; Katarzyna Bogus; Aleksandra Suszka-Świtek; Andrzej Kaśkosz; Shirley Saint-Remy; Aneta Piwowarczyk-Nowak; Łukasz Filipczyk; John J Worthington; Kinga Mordecka-Chamera; Karol Kostro; Grzegorz Bajor; Ryszard Wiaderkiewicz
Journal:  J Neural Transm (Vienna)       Date:  2019-02-15       Impact factor: 3.575

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.